Information for Cagrilintide

Cagrilintide is a long-acting amylin analogue designed with structural modifications—such as α helix stabilization, β-sheet suppression, and lipidation—to enhance peptide stability and extend systemic exposure (Kruse et al. 2021; D’Ascanio et al. 2024). It exhibits high in vitro potency at multiple amylin and calcitonin receptor subtypes and demonstrates prolonged activity through reversible albumin binding and receptor-specific dynamics (Cao et al. 2025).

Cagrilintide 5mg

Research Certificates of Analysis

Cagrilintide
5.57mg
Task #46315
Batch Hcag-0005
08/01/2024

GMP Certificates of Analysis

Cagrilintide
10.29mg
Batch V250606-26 011
06/20/2025
Cagrilintide
10mg
Batch #PKCAGR10924
09/11/2024

Product Usage

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.